{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:34:46Z","timestamp":1789950886396,"version":"4.0.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.ygyno.2014.01.004","type":"journal-article","created":{"date-parts":[[2014,1,10]],"date-time":"2014-01-10T05:12:19Z","timestamp":1389330739000},"page":"606-610","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Hyperinsulinemia is associated with endometrial hyperplasia and disordered proliferative endometrium: A prospective cross-sectional study"],"prefix":"10.1016","volume":"132","author":[{"given":"Weiwei","family":"Shan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1899-3162","authenticated-orcid":false,"given":"Chengcheng","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuezhen","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiongjie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenbo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2014.01.004_bb0005","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/annonc\/mdq464","article-title":"Metabolic syndrome and endometrial cancer risk","volume":"22","author":"Rosato","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ygyno.2014.01.004_bb0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4103\/2230-8210.91175","article-title":"Changing definitions of metabolic syndrome","volume":"16","author":"Parikh","year":"2012","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.ygyno.2014.01.004_bb0015","doi-asserted-by":"crossref","first-page":"355.e1","DOI":"10.1016\/j.ajog.2010.11.033","article-title":"Prospective evaluation of insulin resistance among endometrial cancer patients","volume":"204","author":"Burzawa","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2014.01.004_bb0020","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1158\/1055-9965.EPI-11-0715","article-title":"Case\u2013control study of the metabolic syndrome and metabolic risk factors for endometrial cancer","volume":"20","author":"Friedenreich","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ygyno.2014.01.004_bb0025","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s12029-011-9332-7","article-title":"Dietary, endocrine, and metabolic factors in the development of colorectal cancer","volume":"43","author":"Barone","year":"2012","journal-title":"J Gastrointest Cancer"},{"key":"10.1016\/j.ygyno.2014.01.004_bb0030","first-page":"223","article-title":"Metabolic syndrome and breast cancer: an overview","volume":"17","author":"Gezgen","year":"2012","journal-title":"J BUON"},{"key":"10.1016\/j.ygyno.2014.01.004_bb0035","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1200\/JCO.2009.24.1315","article-title":"Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia","volume":"28","author":"Lacey","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2014.01.004_bb0040","series-title":"Blaustein's pathology of female genital tract","author":"Kurman","year":"2011"},{"key":"10.1016\/j.ygyno.2014.01.004_bb0045","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.2337\/diacare.23.8.1108","article-title":"The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes","volume":"23","author":"Gabir","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ygyno.2014.01.004_bb0050","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1475-2840-9-63","article-title":"Insulin resistance and glycemic abnormalities are associated with deterioration of left ventricular diastolic function: a cross-sectional study","volume":"9","author":"Dinh","year":"2010","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.ygyno.2014.01.004_bb0055","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1590\/S0066-782X2011005000089","article-title":"Insulin resistance and its association with metabolic syndrome components","volume":"97","author":"Medeiros","year":"2011","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.ygyno.2014.01.004_bb0060","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1373\/clinchem.2010.152025","article-title":"Computational methods are significant determinants of the associations and definitions of insulin resistance using the homeostasis model assessment in women of reproductive age","volume":"57","author":"Safar","year":"2011","journal-title":"Clin Chem"},{"key":"10.1016\/j.ygyno.2014.01.004_bb0065","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1210\/jcem.85.7.6661","article-title":"Quantitative Insulin Sensitivity Check Index: a simple, accurate method for assessing insulin sensitivity in humans","volume":"85","author":"Katz","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ygyno.2014.01.004_bb0070","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ygyno.2009.12.029","article-title":"The association between metabolic abnormality and endometrial cancer: a large case\u2013control study in China","volume":"117","author":"Zhang","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.01.004_bb0075","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1677\/ERC-07-0132","article-title":"Metabolic syndrome, plasma lipid, lipoprotein and glucose levels, and endometrial cancer risk in the European Prospective Investigation Into Cancer and Nutrition (EPIC)","volume":"14","author":"Cust","year":"2007","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ygyno.2014.01.004_bb0080","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.2337\/dc12-0336","article-title":"Metabolic syndrome and risk of cancer: a systematic review and meta-analysis","volume":"35","author":"Esposito","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ygyno.2014.01.004_bb0085","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/aje\/kwq006","article-title":"Metabolic syndrome and endometrial carcinoma","volume":"171","author":"Bjorge","year":"2010","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ygyno.2014.01.004_bb0090","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/ijc.27622","article-title":"Serum insulin-like, growth factor binding protein-related protein 1 (IGFBP-rP1) and endometrial cancer risk in Chinese women","volume":"132","author":"Zhan","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2014.01.004_bb0095","doi-asserted-by":"crossref","first-page":"6373","DOI":"10.1158\/1078-0432.CCR-06-0912","article-title":"Overexpression of the insulin-like growth factor I receptor and activation of the AKT pathway in hyperplastic endometrium","volume":"12","author":"McCampbell","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ygyno.2014.01.004_bb0100","doi-asserted-by":"crossref","first-page":"789174","DOI":"10.1155\/2012\/789174","article-title":"Insulin resistance and cancer risk: an overview of the pathogenetic mechanisms","volume":"2012","author":"Arcidiacono","year":"2012","journal-title":"Exp Diabetes Res"},{"key":"10.1016\/j.ygyno.2014.01.004_bb0105","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ygyno.2012.03.032","article-title":"Insulin resistance: a significant risk factor of endometrial cancer","volume":"125","author":"Mu","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.01.004_bb0110","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nrc2536","article-title":"Insulin and insulin-like growth factor signalling in neoplasia","volume":"8","author":"Pollak","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ygyno.2014.01.004_bb0115","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/IGC.0b013e318233e0e1","article-title":"Metformin: a potential novel endometrial cancer therapy","volume":"22","author":"Mu","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2014.01.004_bb0120","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/j.1447-0756.2011.01839.x","article-title":"Metformin sensitizes endometrial cancer cells to chemotherapy by repressing glyoxalase I expression","volume":"38","author":"Dong","year":"2012","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.ygyno.2014.01.004_bb0125","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jsbmb.2010.12.006","article-title":"Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells","volume":"126","author":"Xie","year":"2011","journal-title":"J Steroid Biochem Mol Biol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825814000158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825814000158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,7]],"date-time":"2018-10-07T07:56:10Z","timestamp":1538898970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825814000158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0090825814000158"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2014.01.004","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperinsulinemia is associated with endometrial hyperplasia and disordered proliferative endometrium: A prospective cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2014.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}